Newly diagnosed isolated myeloid sarcoma-paired NGS panel analysis of extramedullary tumor and bone marrow

Ann Hematol. 2021 Feb;100(2):499-503. doi: 10.1007/s00277-020-04313-x. Epub 2020 Oct 27.

Abstract

Isolated myeloid sarcoma (MS) is a rare malignancy in which myeloid blast forms tumors at various locations while the bone marrow (BM) remains cytomorphologically free from disease. We analyzed isolated MS from four patients and their BMs at initial diagnosis and follow-up, using a custom next-generation sequencing (NGS) panel. We observed possible clonal evolution and a clonal hematopoiesis of indeterminate potential (CHIP)-like finding in the BM of one of three cases with detectable mutations. Clinical presentation of one patient suggested extramedullary confined homing of blasts to distal sites in the relapse situation still sparing the BM. In summary, our findings shall motivate future work regarding signals of extramedullary blast trafficking and clonal evolution in MS.

Keywords: CHIP; Clonal evolution; Homing; Myeloid sarcoma; NGS sequencing.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Aged
  • Bone Marrow Neoplasms* / diagnosis
  • Bone Marrow Neoplasms* / genetics
  • Bone Marrow*
  • Clonal Evolution*
  • High-Throughput Nucleotide Sequencing*
  • Humans
  • Male
  • Sarcoma, Myeloid* / diagnosis
  • Sarcoma, Myeloid* / genetics